{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:17:34Z","timestamp":1778908654319,"version":"3.51.4"},"reference-count":51,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1128\/AuthorWarrantyLicense.v1"},{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["mSphere"],"published-print":{"date-parts":[[2018,10,31]]},"abstract":"<jats:p>Numerous outbreaks of mumps have occurred in the United States among two-dose measles-mumps-rubella (MMR)-vaccinated populations since 2006. The avidity of mumps-specific IgG antibodies may affect susceptibility to mumps virus infection in some vaccinated individuals. To accurately measure mumps avidity, we developed and validated a mumps-specific IgG avidity assay that determines avidity at the endpoint titer of serially diluted serum specimens, providing results that are independent of IgG concentration. At low antibody titers, endpoint methods are considered more accurate than methods that determine avidity at a single dilution. We determined that 6\u2009months after the first MMR dose, mumps IgG avidity is high and generally sustained at avidity indices of 40 to 60%, reaching values of &gt;80% in some individuals. Additionally, 4% (4\/103) of individuals had avidity indices of \u226430% (low avidity) 2 years after vaccination. Inadequate mumps avidity maturation may be one factor influencing susceptibility to mumps virus infection among previously vaccinated or naturally infected individuals.<\/jats:p>","DOI":"10.1128\/msphere.00320-18","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T13:31:13Z","timestamp":1536672673000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":17,"title":["Development and Use of an Endpoint Titration Assay To Characterize Mumps IgG Avidity following Measles, Mumps, and Rubella Vaccination and Wild-Type Mumps Infection"],"prefix":"10.1128","volume":"3","author":[{"given":"Sara","family":"Mercader","sequence":"first","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia","family":"McGrew","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun B.","family":"Sowers","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobia J.","family":"Williams","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Bellini","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole J.","family":"Hickman","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6529a2"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1017\/S095026881100063X"},{"key":"e_1_3_2_4_2","article-title":"Notifiable diseases and mortality tables, weekly\/January 5, 2018\/66(52)","author":"Anonymous","year":"2018","unstructured":"Anonymous. 2018. Notifiable diseases and mortality tables, weekly\/January 5, 2018\/66(52). MMWR Morb Mortal Wkly Rep https:\/\/www.cdc.gov\/mmwr\/volumes\/66\/wr\/mm6652md.htm.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202865"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706589"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268812001136"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2015.47.1.1"},{"key":"e_1_3_2_9_2","volume-title":"The immunological basis for immunization series. Module 16: mumps.","author":"McLean HQ","year":"2010","unstructured":"McLean HQ, Hickman CJ, Seward JF. 2010. The immunological basis for immunization series. Module 16: mumps. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/596207"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir526"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu101"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.10.009"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890450104"},{"key":"e_1_3_2_15_2","first-page":"244","article-title":"Anti-rubella, mumps and measles IgG antibodies in medical students of Tehran University","volume":"15","author":"Keshavarz M","year":"2016","unstructured":"Keshavarz M, Nicknam MH, Tebyanian M, Shahkarami MK, Izad M. 2016. Anti-rubella, mumps and measles IgG antibodies in medical students of Tehran University. Iran J Allergy Asthma Immunol 15:244\u2013250.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.5.6.799-803.1998"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.013"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.05.018"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis568"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00895a027"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60414-9"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00013542-199307000-00001"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199703)51:3<242::AID-JMV17>3.0.CO;2-M"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00917569"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21106"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.020"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2007.01727.x"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.8755-8920.2000.440304.x"},{"key":"e_1_3_2_29_2","first-page":"1","article-title":"Mumps surveillance\u2014United States, 1988\u20131993","volume":"44","author":"van Loon FP","year":"1995","unstructured":"van Loon FP, Holmes SJ, Sirotkin BI, Williams WW, Cochi SL, Hadler SC, Lindegren ML. 1995. Mumps surveillance\u2014United States, 1988\u20131993. MMWR CDC Surveill Summ 44:1\u201314.","journal-title":"MMWR CDC Surveill Summ"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2013.01.015"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052939"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu604"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.22134"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.05228-11"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203429"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.09.001"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1894"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00284-10"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00621-13"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-74-5-917"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-011-0358-3"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.8.2139-2144.1992"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(86)90002-9"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(82)90071-4"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit143"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.11.2874-2880.1992"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530330048028"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00406-12"},{"key":"e_1_3_2_49_2","volume-title":"EP05-A3. Evaluation of precision performance of quantitative measurement methods: approved guideline","author":"CLSI","year":"2004","unstructured":"CLSI. 2004. EP05-A3. Evaluation of precision performance of quantitative measurement methods: approved guideline, 2nd ed. CLSI, Wayne, PA.","edition":"2"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.8.1972-1977.1997"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5877(00)00115-X"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.143.1.7063747"}],"container-title":["mSphere"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mSphere.00320-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mSphere.00320-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T04:16:48Z","timestamp":1646713008000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/mSphere.00320-18"}},"subtitle":[],"editor":[{"given":"Marcela F.","family":"Pasetti","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,31]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10,31]]}},"alternative-id":["10.1128\/mSphere.00320-18"],"URL":"https:\/\/doi.org\/10.1128\/msphere.00320-18","relation":{},"ISSN":["2379-5042"],"issn-type":[{"value":"2379-5042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,31]]},"assertion":[{"value":"2018-06-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00320-18"}}